Alasdair is a General Counsel with extensive experience in some of the world’s most successful life sciences companies and law firms. He trained and qualified at Linklaters. Alasdair joined Mundipharma from Thermo Fisher Scientific (the world’s largest life sciences tools and healthcare technologies company) where he served as VP, General Counsel, EMEA. In 2018, he was awarded European General Counsel of the Year by the Association of Corporate Counsel.
He is currently completing an Executive MBA (London Business School) and holds a BSc in Biological Sciences (Edinburgh University). Alasdair is a Certified Director (INSEAD, IDP-C) and holds a Diploma in Company Direction (Institute of Directors).
Alasdair is a Trustee / Non-Executive Director (and Audit and Risk Committee Chair) of the UK Dementia Research Institute, the UK’s single biggest dementia investment, currently with 500 staff, and growing rapidly.
Press return to search